ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGY Allergy Therapeutics Plc

7.40
0.20 (2.78%)
07 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 2.78% 7.40 6.70 7.50 7.24 6.90 7.10 444,115 16:35:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 55.2M -40.22M -0.0084 -8.45 343.18M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 7.20p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 1.88p to 7.25p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £343.18 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -8.45.

Allergy Therapeutics Share Discussion Threads

Showing 4676 to 4695 of 5375 messages
Chat Pages: Latest  191  190  189  188  187  186  185  184  183  182  181  180  Older
DateSubjectAuthorDiscuss
20/4/2023
06:32
What is the full allowance based on? Is it as much as your existing shares or x amount more?
amishp67
19/4/2023
22:24
Gradually recovering my losses with I3e
10% divided a year.monthly dividends
Profitable company.
Growing
T/o eventually

genises
19/4/2023
20:37
Hi. Could somebody kindly explain to me what is going to happen now. I currently hold about 800 shares.
scrappy86
19/4/2023
17:42
I am voting for all resolutions and will take up my full allowance.
Yesterday is dead and gone!

impo

jimmyloser
19/4/2023
06:13
Brilliant.. now I might get to close at 1.1p Instead of 0.1p!A bunch of morons for what they are doing here
amishp67
14/4/2023
18:47
And don't forget there will be nearly five billion confetti shares in circulation soon for this tiny business. It has 0.1p not 10p a share written all over it - with yet more funding required in the near term foreseeable future. I'm ashamed to say I hold.
jpuff
14/4/2023
15:38
I don't understand how it is possible to find positive aspects in this affair. I don't understand how one can hope for the pivotal studies to be successful when the R&D department of this company has never produced a useful clinical study. Never. Ever and never. Not even for key and established products, thus a real pipe dream for a complex and potentially dangerous vaccine for the treatment of peanut allergy. As for business, all European countries are phasing out NPP vaccines from the market and this company has not been able to register a single product to the GCP standards required today. It only has a few vaccines registered here and there with very old procedures from over 20 years ago, when everything and the opposite of everything was registered and which will not be renewed. Vaccines registered in the last 15 years according to GCP standards: zero, zero, zero. Finally, most interesting and most important of all, this management, in all these years has not been able to produce a serious, sustainable and credible industrial development plan that has not always, and I always say, despised itself and its shareholders. Only the naive or those with exclusively personal or personalistic ulterior motives can still believe in this project.
beccasan
14/4/2023
15:35
Jpuff, I fully agree.
beccasan
13/4/2023
06:59
Folk seem to be talking as if the trials are definitely going to be positive. If that were the case we wouldn't be bankrupt with a 1p rescue bid as a punt. This is a very high risk new business - essentially a punt or wild bet!
jpuff
12/4/2023
22:08
A profitable company for several years with two ground breaking trials to
A company who requires 40 million with shareholders left with a value of 1p a share.
The CEO should retire as he the main man who has led the investors to this debacle.
Not fit to be running a company.
All to happen before the ground breaking trials are completed.
Wonder how much the company would be worth when positive results come out

genises
12/4/2023
20:59
I agree with you 1kckeith, if we are not to be wiped out there is no alternative but to follow the money. There seem to be two things to consider, firstly, all that has gone before has to be put out of one’s mind and the fact that we have all probably lost a great deal of our original investment is history. Secondly, the company is now effectively controlled by, I would suspect, a couple of pretty sharp private equity/ venture capital investors. It is not in their interest to turn the established order upside down right now but I would guess their hand are very much on the controls and when the time is right I hope and believe they will put in people better able to achieve their objectives than the skeleton crew who are currently supposedly at the helm. They will be keen to get through this time without any further tsunamis.

So, we may well now have an opportunity to venture a penny a share with the potential of something better so long as the wheels don’t come off the cash flow projections in the coming fairly precarious months.

One aside but nonetheless quite an interesting aspect is that the Company no longer has any charges over its assets, following the recent removal of the NatWest fixed and floating charge. It’s not often that a company teaters on the edge of bankruptcy with wholly unencumbered assets. This situation will presumably change as soon as the investors put up their temporary loan capital. If things then go wrong for any reason and there is a breach in the covenant conditions you can be sure they will swoop and take 100% control wiping out the minorities at a stroke. This should be more difficult for them to do once the new shares have all be subscribed but the the documents would have to be examined very carefully to establish whether that is the case.

Nil desperandum

stablehound
12/4/2023
07:23
Just had my monthly dividend announced from I3e every little helps.
genises
12/4/2023
07:21
CEO should be sacked
It obvious they lost significant contracts from other companies.

genises
11/4/2023
10:15
Where are they going to get further funding from going forward? This is my biggest concern to be honest, otherwise I agree with the risk of the open offer. The problem is whats next when they run out of money again?
amishp67
11/4/2023
10:13
I will not be subscribing following the debacle. I will write off my holding in entirety as a bad investment (though no one could have predicted the chain of events). The residual holding will simply sit on my portfolio for the foreseeable future in the grim hope of some recovery due to trial successes. Classic example of how to turn a good company bad!
catch007
11/4/2023
10:05
I agree with you Jpuff but not with your decision not to throw good money after bad (even though it does strongly feel that way).
Having thought about this over Easter, I think I will be taking up the Open Offer. This is the only way to avoid being wiped out, as you put it in the first post. I agree that there should be a consolidation, but that does not impinge upon value (other than positively by making the shares more easily traded).
Here is my thinking on the Open Offer:
At the 1p price, with the post-deal shares in issue of over 4.7bn, the market cap will be £47m. As the company was trading in the 20p-30p range for a significant part of the recent past, which valued the equity at £130m - £200m, and as the underlying business is not changed by this Episode of crass shareholder value destruction, the 1p shares might have a 'true' value of 3p - 4p. But you can only buy them for 1p via the Open Offer. Given that you will be allowed 6 x your current holding in 1p Open Offer shares, this potential upside of 2-3p per share is 'worth' 12p - 18p per share held prior to the Episode of imbecilic mismanagement. But to get this you need to chuck quite a lot of good money after bad, and (I suspect) be quite patient as things settle down and trading is even thinner than before the Episode of [fill in your own words here, but keep it clean...].
I am not advising you to do this, just explaining why I might.
POSSIBLE ISSUES include:
- the company still needs more financing within 3-9 months ('H2'). There is a non-trivial risk of the Consortium providing this on terms further damaging the 'outside' shareholder.
- Other decisions unpalatable to the small outside investor can be made without consultation owing the the Consortium having 80 - 90%+
- as you say, there is no sign that the management of the company will change, so investors remain exposed to the risk of recurring Episodes

1kckeith
11/4/2023
05:33
And finally, what's the betting that the directors who managed this utter failure of a business get handsomely rewarded for their achievements? I'm one hundred percent certain of that!
jpuff
10/4/2023
21:51
Oh and with several billion shares now in circulation it's more likely to go to 0.1p than 10p and no doubt followed by a 100 to 1 consolidation as the icing on the cake.
jpuff
10/4/2023
21:38
The way I see it is firstly I've been wiped out here as a long term investor. Now looking at this company afresh as a newcomer would I want to invest in it? Yes it No? Probably no for me, so I won't be throwing good money after bad. I'll move on and erase from my memory and monitor!
jpuff
07/4/2023
14:19
Good summary my friend. Thanks.
richtea2517
Chat Pages: Latest  191  190  189  188  187  186  185  184  183  182  181  180  Older

Your Recent History

Delayed Upgrade Clock